Please login to the form below
Genentech
This page shows the latest Genentech news and features for those working in and with pharma, biotech and healthcare.
Paris Court of Appeal overturns Novartis and Roche’s €444m anti-competitiveness fine
The fine has now been overturned, which was originally 385.1m against Novartis and 59.7m against Roche and its subsidiary Genentech, with the appeals court concluding that the companies had
Latest news
-
Pistoia Alliance launches free guide on implementing FAIR principles in clinical data
The guide was co-authored by the Pistoia Alliance and leading experts in the field, which included AstraZeneca, Roche, Bayer, Genentech, Galapagos, the Hyve, Elixir, the University of Manchester and Oxford
-
Genentech reports positive phase 3 data for its Tecentriq combination in liver cancer
Tecentriq in combination with Avastin significantly improved recurrence-free survival. Genentech – a member of the Roche group – has announced that its phase 3 study of Tecentriq (atezolizumab) combination mets its primary ... Results from the study
-
Genentech and Kronos Bio announce oncology partnership worth over $570m
Genentech – a member of the Roche group – and Kronos Bio (Kronos) have entered into a discovery collaboration to advance novel therapies for transcriptional targets in oncology. ... The collaboration will focus on discovering and developing
-
Biogen and Genentech sign royalty agreement for blood cancer drug glofitamab
Genentech will have sole decision-making rights on glofitamab's commercialisation in the US. ... partners’ antibody portfolio, by paying a $30m one-time option fee to Genentech as well as covering a portion of the 2021 development expenses.
-
Genentech shares positive two-year data for Evrysdi in spinal muscular atrophy study
Genentech – a member of the Roche group – has announced new two-year data from its JEWELFISH study evaluating Evrysdi (risdiplam) in patients with type 1, 2 or 3 spinal muscular atrophy ... Levi Garraway, Genentech’s chief medical officer and head
More from news
Approximately 22 fully matching, plus 253 partially matching documents found.
Latest Intelligence
-
Are healthcare brands finally wising up to the power of creative-led communications?
And the list goes on. So it seems, encouragingly, that health and pharma brands – from Pfizer to Teva and Roche Genentech to Janssen – seem to finally be recognising the power of
-
20 for 2020 – Five pharma leaders to watch in 2020
Analysts think the deal could catapult Galapagos into the top tier of biopharma companies, joining the likes of Regeneron, Biogen and Roche’s Genentech unit, providing its pipeline delivers as hoped
-
Can protein degraders unlock ‘undruggable’ drug targets?
which adds to previous collaborations with Roche’s Genentech subsidiary, Pfizer, and also Merck &Co/MSD that committed $434m to the company shortly after it launched in 2013.
-
A snapshot of Microbiotica
There is also a $534m collaboration with Roche’s Genentech and an investment from Paris-based microbiome specialist VC Seventure.
-
Building European biotech firms to rival those of the US
of the US success stories of Amgen, Genentech and others.
More from intelligence
Approximately 0 fully matching, plus 33 partially matching documents found.
Latest appointments
-
New hires at Abbott, Kite and Arrakis Therapeutics
Prior to BioMarin, Calderaro was the vice president of technical product management at Genentech.
-
New hires at Amgen, Eli Lilly and Zosano
Earlier in his career, Lo spent 13 years at Roche Group’s Genentech in roles of increasing responsibility in sales and marketing, ultimately serving as franchise head for endocrinology.
-
BMS appoints new commercial leader, Davies joins Eisai and more
He has also held a number of roles for Dendreon Corporation and Roche’s Genentech, where he worked on its Avastin franchise strategy.
-
Juno Therapeutics names Cindy Elkins as CIO
She joins the biopharma from Genentech, where she was VP of IT. ... Elkins most recently served as vice president, IT for the Americas at Genentech, where she led its US commercial technology integration following the firm's acquisition by Roche.
-
Revolution Medicines appoints Dr Stephen Kelsey
Prior to his time at Onkaido Therapeutics, Kelsey has served in several senior positions at Medivation, Generon and Genentech, where he held the role of vice president, haematology and oncology.
More from appointments
Approximately 1 fully matching, plus 28 partially matching documents found.
Latest from PMHub
-
September 2020: diversity and inclusion in clinical trials round-up
A recent study by Genentech aimed to get to the heart of the patient experience by interviewing over 2000 patients about their interactions with the healthcare system.
-
July 2020: diversity and inclusion in clinical trials round-up
Genentech make effort to boost diversity and inclusion in COVID-19 treatment studies. ... Genentech are also running the EMPACTA study, which will recruit patients from underserved communities.
-
Outsourcing in Clinical Trials 2020 Virtual Conference
trials. Meghan McKenzie, Genentech highlighted that disease pattern, clinical presentation and therapeutic response can vary dramatically with ethnicity and ancestral background. ... It was great to see that Genentech is trying to act based on insights
-
Augmented Reality in patient communication – don’t miss out!
Electronic Informed Consent Forms (e-ICFs) and Electronic Data Capture (EDC). In a recent well written article, Pierre Corin from Genentech discussed the drivers, advantages and possible challenges of using electronic ... References:. Pierre Corin,
-
It's time to change the conversation
Changing the conversation with patients. One of the earliest adopters of technology and social media to change the conversation with patients, was Genentech. ... Starting from the position of caring about the patient, Genentech created the Herceptin
More from PMHub
Approximately 0 fully matching, plus 6 partially matching documents found.
Subscribe to our email news alerts
-
Pharmacovigilance Project Lead
- Highly competitive salary
- Early Access Program - Regulatory Affairs (EAP-RA)
- Highly competitive salary
-
Senior Medical Writer
- Highly competitive salary
-
Pharmacovigilance Manager
- Highly competitive salary
-
Omnichannel Account Director
- £55,000 - £65,000 yearly
-
Technical Sales Representative
- Highly competitive salary
- Novo Nordisk suspended from ABPI over ‘serious’ code of practice breaches
- BMS will not launch cancer drug Opdualag in Germany due to pricing pressures
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- LEO Pharma enters clinical trial partnership with ICON
- Results for Astellas’ non-hormonal menopause drug published in The Lancet
- Roche’s Polivy backed by FDA Advisory Committee for lymphoma therapy
- DIGITAL EXPERIENCES: LEARNINGS FROM OUTSIDE PHARMA
- WHY ARE PATIENT SUPPORT PROGRAMMES NOT WORKING?
- THE EVOLVING ROLE OF PROCUREMENT?
- Origins' Solutions Offering Explained
- Pfizer pays Royalty Pharma $475m following US approval of migraine nasal spray
- Alzheimer’s Association report highlights need to improve patient-physician communication
- Locus Biosciences announces first patient treated in urinary tract infection trial
- A relentless commitment to neuroscience
- Eli Lilly announces 70% cut to US insulin prices while also capping out-of-pocket costs
- Merck signs $922m deal with Opko Health unit for Epstein-Barr vaccine candidate
- Origins Insights Offering Explained
- Neurodiversity and healthcare communications – do we know enough and do we do enough?
PMHub
EPG Health
REACH, ENGAGE & MEASURE HCPs ONLINE - Accomplish meaningful engagement via Medthority (www.medthority.com), a trusted independent medical website. Support the...
Latest intelligence
- DIGITAL EXPERIENCES: LEARNINGS FROM OUTSIDE PHARMA
- It’s long been the case that pharma lags behind other industries when it comes to digital adoption and engagement. So, what can we learn from these other industries, and how...
- WHY ARE PATIENT SUPPORT PROGRAMMES NOT WORKING?
- By offering patients knowledge, skills and confidence, they empower patients to be more actively involved in their health. Holistic support can help tackle adherence, mental health or anything else patients...
- THE EVOLVING ROLE OF PROCUREMENT?
- Procurement is evolving to reinforce its position as a strategic enabler of company growth. How can agency partners organisations to realise this?...
